Send us a text

The Oncology Podcast - Delivering Oncology News Differently

Welcome to episode 6 in ourExperts On Point podcast series brought to you from The Oncology Podcast.

Today's podcast explores the role of theranostics in neuroendocrine tumours - in celebration of World NET Cancer Day on the 10th November 2021.

Rachael Babin chats to Simone Leydon and Aviral Singh about the future of theranostics in Australia.

Simone Leyden is CEO, and Co-Founder of NeuroEndocrine Cancer Australia. Dr Aviral Singh who is a Specialist Nuclear Medicine Physician from Germany and Clinical Research and Development Manager for GenesisCare. He practices Theranostics for the management of Neuroendocrine Neoplasms and Prostate Cancer.

We hope you enjoy today's episode.

For news and podcast updates subscribe to the The Oncology Newsletter,  a free weekly publication for healthcare professionals with an interest in oncology. Click here to subscribe.

PART OF THE ONCOLOGY NETWORK